TwitterRSSFacebookDirectors Blog
  Disorders A - Z:   A    B   C    D    E    F    G    H    I    J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z

Skip secondary menu

NINDS Neuroscience Funding Announcements

NINDS Competing Renewal Awards of STTR Phase II (Phase IIB) Grants (STTR [R42])

Funding Contact(s): Stephanie Fertig, MBA
Funding Categories: Small Business

Brief Description:

This Funding Opportunity Announcement (FOA) encourages Small Business Technology Transfer (STTR) applications from small business concerns (SBCs) that seek additional funding to support the next stage of development for projects requiring approval from a Federal regulatory agency. The FOA aims to facilitate the transition of previously funded STTR Phase II projects to the commercialization stage by promoting partnerships between NIH’s STTR awardees and third-party investors and/or strategic partners. Consistent with the goals of this funding initiative and as required by the SF424 instructions for all STTR Phase II applications, applicants must submit a Commercialization Plan, which should include details on any independent third-party investor funding that has already been secured or is anticipated during the project period. It is expected that the level of this independent third-party funding will be equal to or greater than the NINDS funds being requested throughout the STTR Phase IIB project period.

Grant Mechanism: R42
NIH Guide: PAR-12-076
Release Date: 2012-01-11
Expiration Date: 2013-09-08